Selected Abstracts

A Proof of principle study: Diagnosing MS by analyzing the CSF cell transcriptome

B.H. Yoon, A. Mueller, E. Franzova, and S. Sadiq. Presented at the 65th annual meeting of the American Academy of Neurology, held March 16-23, 2013 in San Diego, CA.

Identification of CSF biomarkers of cognitive impairment and cerebellar dysfunction in multiple sclerosis

L.H. Bell, V.K. Harris, and S.A. Sadiq. Presented at the 65th annual meeting of the American Academy of Neurology, held March 16-23, 2013 in San Diego, CA.

Read Abstract

Transglutaminase 6 antibodies are elevated in the serum of multiple sclerosis patients

M. Cristofanilli, J. Goldberg, D. Bates, and S.A. Sadiq. Presented at the 2012 meeting of the Society for Neuroscience, held October 13-17, 2013 in New Orleans, LA.

Read Abstract

Do Immunological Profiles of the Cerebrospinal Fluid Correlate with Disease Severity in Multiple Sclerosis?

Edward Brydon, PhD, Emma Marszal, BA and Saud Sadiq, MD, MB. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Safety of Long-Term Intrathecal Methotrexate Therapy in Progressive Forms of Multiple Sclerosis

James Stark, Deirdre Dulak, and Saud A. Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Accurate Risk Assessment for the Development of PML in Natalizumab Treated MS Patients Requires CSF Analysis

Peggy Bettin, Jerry Lin, and Saud A. Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Neuroketals in the cerebrospinal fluid of multiple sclerosis patients

Donald Lee, Fozia Mir and Saud Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro

Barbara Cymring, Massimiliano Cristofanilli, Amy Lu, Hannah Rosenthal, and Saud A. Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Lipid peroxidation products as novel biomarkers in the cerebrospinal fluid of Multiple Sclerosis patients

Fozia Mir. Presented at the annual meeting of the American Society of Neurochemistry held March 3-7 in Baltimore, MD.

Read Abstract

MS disease activity inhibits hepatocyte growth factor (HGF) production within the CNS - a new putative mechanism contributing to lack of lesion repair seen in MS

A.M. Mueller, E. Jun, H. Conlon, S. Sadiq. Nov 14th 2011. Platform presentation at the 2011 meeting of the Society for Neuroscience, Washington DC, USA.

Read Abstract

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.